VIEW WEBSITE >>

Atlanta, US · 2 known investors

Kodikaz develops Zip-Code, a non-viral cell-specific delivery platform for gene therapy applications, particularly focused on oncology and cancer treatments. The company serves oncologists and patients with cancer seeking advanced therapeutic solutions.

AI & Machine LearningBiotechMedical Devices